drugset / Trial / NCT03947411
Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
Unknown
72 enrolled
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine · collabBeijing Luhe Hospital · collabCangzhou People's Hospital · collabQingdao Municipal Hospital · collabThe First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multicenter, randomized, open Label, add-on study.
Timeline
- Start
- 2019-03-04
- Primary completion
- 2020-03-31
- Completion
- 2020-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xiyanping | Unknown | — | Intravenous |
| Comparator | Oseltamivir | Small molecule | — | — |